Hexokinase 2-mediated Warburg effect is required for PTEN- and p53-deficiency-driven prostate cancer growth.
Hexokinase 2-mediated Warburg effect is required for PTEN- and p53-deficiency-driven prostate cancer growth.
复制标题
DOI:
10.1016/j.celrep.2014.07.053
复制
发表时间:
2014-09-11
期刊:
影响因子:
8.8
通讯作者:
Deng Y
中科院分区:
文献类型:
--
作者:
Wang L;Xiong H;Wu F;Zhang Y;Wang J;Zhao L;Guo X;Chang LJ;Zhang Y;You MJ;Koochekpour S;Saleem M;Huang H;Lu J;Deng Y
Accumulating evidence suggests that co-deletion of tumor suppressor genes Pten and p53 plays a crucial role in the development of castration-resistant prostate cancer in vivo. However, the molecular mechanism underlying Pten/p53-deficiency driven prostate tumorigenesis remains incompletely understood. Building upon insights gained from our studies with Pten/p53-deficient mouse embryonic fibroblasts (MEFs), we report here that hexokinase 2 (HK2) is selectively upregulated by the combined loss of Pten and p53 in prostate cancer cells. Mechanistically, Pten deletion increases HK2 mRNA translation through activation of the AKT-mTORC1-4EBP1 axis and p53 loss enhances HK2 mRNA stability through inhibition of miR143 biogenesis. Genetic studies demonstrate that HK2-mediated aerobic glycolysis, known as the Warburg effect, is required for Pten/p53-deficiency driven tumor growth in xenograft mouse models of prostate cancer. Our findings suggest that HK2 might be a therapeutic target for prostate cancer patients carrying Pten and p53 mutations.
登录
查看更多内容
影响因子:
64.5
作者:
Jacinto, Estela;Facchinetti, Valeria;Su, Bing
通讯作者:
Su, Bing
影响因子:
4.8
作者:
Fang, Rong;Xiao, Tian;Ji, Hongbin
通讯作者:
Ji, Hongbin
影响因子:
10.5
作者:
Chen, Mei-Ling;Xu, Pei-Zhang;Hay, Nissim
通讯作者:
Hay, Nissim
影响因子:
30.8
作者:
Jonkers, J;Meuwissen, R;Berns, A
通讯作者:
Berns, A
影响因子:
64.5
作者:
Fang, Min;Shen, Zhirong;Wang, Xiaodong
通讯作者:
Wang, Xiaodong